Mycophenolate therapy in interstitial pneumonia with autoimmune features: a cohort study.

Ther Clin Risk Manag · 2018 · PMC6219314 · PMID 30464490

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

5 – 7 Although we did not find a difference in PFT change or mortality in mycophenolate-exposed compared to unexposed patients, mycophenolate-exposed patients showed a trend toward lower baseline PFT scores and greater decline in PFT scores that began preexposure.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Bronchoalveolar lavage tended to be lymphocyte-predominant in the mycophenolate group, although this finding did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.